ONCO3 Company Description
Oncoclínicas do Brasil Serviços Médicos S.A. provides healthcare services focused on oncology, hematology, and radiotherapy in Latin America.
It offers diagnosis and treatment services, such as pathological analysis, cryotherapy, palliative care, delife, hilotherapy, molecular journey, laser therapy, integrative medicine, myelogram-bone marrow biopsy, OC care line, OC precision medicine, oncoACCESS, survivorship, telemedicine, genetic testing, personalized medicine and individualized treatment, and veinviewer.
The company also provides services in the areas of chemotherapy, hormone therapy, molecular target drugs, immunotherapy, bone marrow transplant, catheter salinization and heparinization, and non-oncological infusions.
The company was founded in 2010 and is based in São Paulo, Brazil.
Country | Brazil |
Founded | 2010 |
Industry | Medical Care Facilities |
Sector | Healthcare |
CEO | Bruno Ferrari |
Contact Details
Address: Avenida Presidente Juscelino Kubitschek São Paulo, 04543-906 Brazil | |
Website | grupooncoclinicas.com |
Stock Details
Ticker Symbol | ONCO3 |
Exchange | Brazil Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | BRL |
ISIN Number | BRONCOACNOR6 |
SIC Code | 8011 |
Key Executives
Name | Position |
---|---|
Bruno Lemos Ferrari | Vice Chairman and Chief Executive Officer |
Cristiano Affonso Ferreira de Camargo | Chief Financial and Investor Relations Officer |
Andre Paranzini Faria | Director of Operations |
Ricardo da Silva Santoro | Chief Technology Officer |
Cinthia Maria Ambrogi | Director of Compliance and Legal |
Guilherme Gimenes Ferri | Marketing Officer |
Giovane Reus Nichele da Costa | Human Resources Officer |
Joao Carlos Figueiredo Padin | Chief Strategy Officer and Board Member |
Rodrigo Ferreira Medeiros da Silva | Executive Vice President |